Free Newsletter
ALSO NOTED: Eisai withdraws European Aricept application; FDA approves GSK's Altabax; and much more...
> Japan's Eisai has withdrawn its European application for Aricept as a treatment for Alzheimer's after regulators asked for more data. Report
> Novelos Therapeutics is planning a $15 million private placement. Release
> The FDA has approved GlaxoSmithKline's antibacterial Altabax. Report
> India's Lupin Pharmaceuticals has received FDA approval for a new formulation of its anti-infective Suprax. Release
> Alkermes announced that the FDA has approved a new dose of risperidone for schizophrenia. Report
And Finally... Indian officials are on alert after an outbreaK of bird flu in Bangladesh. Report






Click here to get the FierceBiotech email newsletter for FREE!
Be the first to comment